Related Experiment Video
Updated: Dec 25, 2025

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
Published on: February 4, 2018
What was lost, missing, sought and hoped for: Qualitatively exploring medical crowdfunding campaign narratives for
Anika Vassell1, Valorie A Crooks1, Jeremy Snyder1
1Simon Fraser University, Canada.
Insights
Canadian Lyme disease patients facing diagnostic and treatment challenges increasingly use medical crowdfunding. Narratives reveal common themes of loss, unmet needs, and hopes for recovery, highlighting the personal impact of this contested illness.
Area of Science:
- Medical Sociology
- Public Health Communication
- Digital Health Humanities
Background:
- Lyme disease is a contested illness in Canada, complicating patient diagnosis and treatment.
- Patients face difficulties accessing timely and appropriate healthcare, leading to unmet needs.
- Medical crowdfunding is emerging as a strategy for patients to fund alternative therapies and manage living costs.
Purpose of the Study:
- To qualitatively explore narratives within Canadian medical crowdfunding campaigns for Lyme disease.
- To identify common themes and elements shared across these personal fundraising appeals.
- To understand how individuals communicate health needs in the context of a contested illness on public platforms.
Main Methods:
- Thematic analysis of 238 crowdfunding campaign narratives from three major platforms.
- Qualitative exploration of personal stories shared by individuals seeking funds for Lyme disease diagnosis or treatment.
Main Results:
- Four consistent themes emerged: 'what is lost' (e.g., bodily function), 'what is missing' (e.g., local care), 'what is sought' (e.g., funds for treatment abroad), and 'what is hoped for' (e.g., return to wellbeing).
- These themes underscore the emotional and personal nature of crowdfunding for a contested illness.
- Campaigns reveal the challenges patients face in validating their financial needs publicly.
Conclusions:
- Medical crowdfunding narratives for Lyme disease offer insights into patient experiences with a contested illness.
- The findings highlight the intersection of personal health, financial need, and public communication.
- Future research could explore the advocacy potential of these crowdfunding narratives.
Abstract:
Lyme disease remains a contested illness in Canada, thereby making the diagnostic and treatment journeys difficult for some people. One outcome of this is that increasing numbers of people are turning to medical crowdfunding to support access to alternative therapies, non-local health care providers and assist with managing the costs of everyday life. In this analysis, we qualitatively explore the narratives shared in Canadians' crowdfunding campaigns to support Lyme disease treatment or diagnosis to identify whether or not any common elements shared in these narratives exist, and if so, what they are. We identified 238 campaigns for inclusion from three prominent crowdfunding platforms. Thematic analysis of the campaign narratives shows four consistent themes shared in these campaigns: what is lost (e.g. bodily ability), what is missing (e.g. local care options), what is sought (e.g. funds to cover treatment abroad) and what is hoped for (e.g. return to wellbeing). These themes demonstrate the highly personal and emotional nature of medical crowdfunding, particularly in the context of a contested illness that may lead some to question the legitimacy of one's financial need. This analysis contributes valuable new insights to the nascent scholarship on medical crowdfunding, and particularly to our understanding of how people communicate about their health and bodily needs on this public platform. It also identifies important directions for future research, including the potential for crowdfunding narratives to be used for advocacy.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Clinical Trials
There are four phases in a clinical trial. A phase one...

